BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30659195)

  • 1. Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming.
    Xiong L; Wu F; Wu Q; Xu L; Cheung OK; Kang W; Mok MT; Szeto LLM; Lun CY; Lung RW; Zhang J; Yu KH; Lee SD; Huang G; Wang CM; Liu J; Yu Z; Yu DY; Chou JL; Huang WH; Feng B; Cheung YS; Lai PB; Tan P; Wong N; Chan MW; Huang TH; Yip KY; Cheng AS; To KF
    Nat Commun; 2019 Jan; 10(1):335. PubMed ID: 30659195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of CCAAT/enhancer binding protein-beta (C/EBPbeta) in epigenetic regulation of mouse methionine adenosyltransferase 1A gene expression.
    Ikeda R; Nishida T; Watanabe F; Shimizu-Saito K; Asahina K; Horikawa S; Teraoka H
    Int J Biochem Cell Biol; 2008; 40(9):1956-69. PubMed ID: 18346930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Super-Enhancer Landscape in Human Hepatocellular Carcinoma.
    Tsang FH; Law CT; Tang TC; Cheng CL; Chin DW; Tam WV; Wei L; Wong CC; Ng IO; Wong CM
    Hepatology; 2019 Jun; 69(6):2502-2517. PubMed ID: 30723918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene.
    Manoharan H; Babcock K; Pitot HC
    Mol Carcinog; 2004 Sep; 41(1):1-16. PubMed ID: 15352122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional and translational regulation of C/EBPβ-HDAC1 protein complexes controls different levels of p53, SIRT1, and PGC1α proteins at the early and late stages of liver cancer.
    Jin J; Iakova P; Jiang Y; Lewis K; Sullivan E; Jawanmardi N; Donehower L; Timchenko L; Timchenko NA
    J Biol Chem; 2013 May; 288(20):14451-14462. PubMed ID: 23564453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements.
    Wu Y; Chen X; Zhao Y; Wang Y; Li Y; Xiang C
    Stem Cell Res Ther; 2019 May; 10(1):151. PubMed ID: 31151404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer.
    Jiang Y; Iakova P; Jin J; Sullivan E; Sharin V; Hong IH; Anakk S; Mayor A; Darlington G; Finegold M; Moore D; Timchenko NA
    Hepatology; 2013 Mar; 57(3):1098-106. PubMed ID: 23172628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/enhancer binding protein β (C/EBPβ) isoforms as transcriptional regulators of the pro-invasive CDH3/P-cadherin gene in human breast cancer cells.
    Albergaria A; Resende C; Nobre AR; Ribeiro AS; Sousa B; Machado JC; Seruca R; Paredes J; Schmitt F
    PLoS One; 2013; 8(2):e55749. PubMed ID: 23405208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2.
    Stefanska B; Suderman M; Machnes Z; Bhattacharyya B; Hallett M; Szyf M
    Carcinogenesis; 2013 Dec; 34(12):2738-49. PubMed ID: 23955541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
    Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
    BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
    Cho IJ; Ki SH; Brooks C; Kim SG
    Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.
    Fang T; Cui M; Sun J; Ge C; Zhao F; Zhang L; Tian H; Zhang L; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li H; Li J
    Oncotarget; 2015 Jun; 6(18):16106-19. PubMed ID: 25965830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells.
    Chen KG; Sale S; Tan T; Ermoian RP; Sikic BI
    Mol Pharmacol; 2004 Apr; 65(4):906-16. PubMed ID: 15044620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
    Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
    Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
    Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting Edge: CRISPR-Based Transcriptional Regulators Reveal Transcription-Dependent Establishment of Epigenetic Memory of
    Cameron J; Martino P; Nguyen L; Li X
    J Immunol; 2020 Dec; 205(11):2953-2958. PubMed ID: 33139491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
    Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
    Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBPβ is AMP kinase sensitive and up-regulates PEPCK in response to ER stress in hepatoma cells.
    Choudhury M; Qadri I; Rahman SM; Schroeder-Gloeckler J; Janssen RC; Friedman JE
    Mol Cell Endocrinol; 2011 Jan; 331(1):102-8. PubMed ID: 20797423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.